Literature DB >> 16768305

Endoscopic third ventriculostomy in the treatment of hydrocephalus in pediatric patients.

C Di Rocco1, G Cinalli, L Massimi, P Spennato, E Cianciulli, G Tamburrini.   

Abstract

Advances in surgical instrumentation and technique have lead to an extensive use of endoscopic third ventriculostomy in the management of pediatric hydrocephalus. The aim of this work was to point out the leading aspects related to this technique. After a review of the history, which is now almost one century last, the analysis of the endoscopic ventricular anatomy is aimed to detail normal findings and possible anatomic variations which might influence the correct conclusion of the procedure. The overview of modern endoscopic instrumentation helps to understand the technical improvements that have contributed to significantly reduce the operative invasiveness. Indications are analysed from a pathogenetic standpoint with the intent to better understand the results reported in the literature. A further part of the paper is dedicated to the neuroradiological and clinical means of outcome evaluation, which are still a matter of debate. Finally a review of transient and permanent surgical complications is performed looking at their occurrence in different hydrocephalus etiologies.

Entities:  

Mesh:

Year:  2006        PMID: 16768305     DOI: 10.1007/3-211-32234-5_4

Source DB:  PubMed          Journal:  Adv Tech Stand Neurosurg        ISSN: 0095-4829


  15 in total

1.  Interhypothalamic adhesions in endoscopic third ventriculostomy.

Authors:  David Phillips; David A Steven; Patrick J McDonald; Jay Riva-Cambrin; Abhaya V Kulkarni; Vivek Mehta
Journal:  Childs Nerv Syst       Date:  2019-06-06       Impact factor: 1.475

Review 2.  Myelomeningocele: the management of the associated hydrocephalus.

Authors:  G Tamburrini; P Frassanito; K Iakovaki; F Pignotti; C Rendeli; D Murolo; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

Review 3.  Ventricular endoscopy in the pediatric population: review of indications.

Authors:  Omar Choudhri; Abdullah H Feroze; Jay Nathan; Samuel Cheshier; Raphael Guzman
Journal:  Childs Nerv Syst       Date:  2014-08-01       Impact factor: 1.475

Review 4.  Neuroendoscopy for post-infective hydrocephalus in children.

Authors:  Chandrashekhar E Deopujari; Llewelyn Padayachy; Alias Azmi; Anthony Figaji; Saurav K Samantray
Journal:  Childs Nerv Syst       Date:  2018-08-11       Impact factor: 1.475

5.  Neuroendoscopy in the management of pineal tumors.

Authors:  Tai-Tong Wong; Hsin-Hung Chen; Muh-Lii Liang; Yu-Shu Yen; Feng-Chi Chang
Journal:  Childs Nerv Syst       Date:  2011-02-23       Impact factor: 1.475

Review 6.  Recent technological advances in pediatric brain tumor surgery.

Authors:  Bassel Zebian; Francesco Vergani; José Pedro Lavrador; Soumya Mukherjee; William John Kitchen; Vita Stagno; Christos Chamilos; Benedetta Pettorini; Conor Mallucci
Journal:  CNS Oncol       Date:  2016-12-21

Review 7.  Hydrocephalus in aqueductal stenosis.

Authors:  Giuseppe Cinalli; Pietro Spennato; Anna Nastro; Ferdinando Aliberti; Vincenzo Trischitta; Claudio Ruggiero; Giuseppe Mirone; Emilio Cianciulli
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

8.  Endoscopic third ventriculocisternostomy in hydrocephalic children under 2 years of age: appropriate or not? A single-center retrospective cohort study.

Authors:  L Fani; T H R de Jong; R Dammers; M L C van Veelen
Journal:  Childs Nerv Syst       Date:  2012-11-13       Impact factor: 1.475

9.  On the changing epidemiology of hydrocephalus.

Authors:  Luca Massimi; Giovanna Paternoster; Teresa Fasano; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2009-02-24       Impact factor: 1.475

10.  Endoscopic third ventriculostomy for obstructive hydrocephalus in children younger than 6 months of age: is it a first-choice method?

Authors:  Radim Lipina; Stefan Reguli; Viera Dolezilová; Marie Kuncíková; Hana Podesvová
Journal:  Childs Nerv Syst       Date:  2008-03-15       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.